Bansri S Furia

Title: Bansri S Furia: Innovator in Spinal Muscular Atrophy Research

Introduction

Bansri S Furia is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of genetic research, particularly in the treatment of spinal muscular atrophy (SMA). With a focus on innovative solutions, Bansri has been instrumental in developing new methods for addressing this challenging condition.

Latest Patents

Bansri S Furia holds 2 patents related to his groundbreaking work. His latest patents include:

1. **Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulation** - This invention provides compounds and assays for identifying and validating compounds that can be used in the treatment of spinal muscular atrophy (SMA). These compounds are designed to up-regulate the post-transcriptional expression of SMN1 or SMN2.

2. **Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation** - This patent also focuses on compounds and assays for the treatment of SMA, emphasizing the up-regulation of SMN1 or SMN2.

Career Highlights

Bansri is currently associated with PTC Therapeutics, Inc., where he continues to advance his research in genetic therapies. His work is pivotal in the ongoing efforts to find effective treatments for SMA, a condition that affects motor neurons and leads to muscle weakness.

Collaborations

Bansri collaborates with talented individuals in his field, including Anuradha Bhattacharyya and Meenal Patel. Their combined expertise contributes to the innovative research being conducted at PTC Therapeutics.

Conclusion

Bansri S Furia is a dedicated inventor whose work in spinal muscular atrophy research is making a significant impact. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.